Condition (MeSH)
Liver Cirrhosis, Experimental
ClinicalTrials.gov lists 2 trials for Liver Cirrhosis, Experimental or a narrower condition beneath it. French National Agency for Research on AIDS and Viral Hepatitis has the most among industry and government lead sponsors, with 1.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
2 of the 2 trials are tagged with Liver Cirrhosis, Experimental itself; the rest are tagged with a narrower condition beneath it.
When did Liver Cirrhosis, Experimental trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2012 | 1 |
| 2002 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 2 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Liver Cirrhosis, Experimental trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 2/3 | 1 |
How many Liver Cirrhosis, Experimental trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Liver Cirrhosis, Experimental trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| French National Agency for Research on AIDS and Viral Hepatitis | 1 |
Which publications cover Liver Cirrhosis, Experimental? (29)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Inflammation remains a dynamic component of portal hypertension in regressive alcohol-related cirrhosis. | United European gastroenterology journal | 2025 | Yes |
| Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation. | Gut | 2021 | Yes |
| FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis. | Journal of hepatology | 2019 | Yes |
| Molecular hepatoprotective effects of lipoic acid against carbon tetrachloride-induced liver fibrosis in rats: Hepatoprotection at molecular level. | Human & experimental toxicology | 2018 | Yes |
| Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice. | Hepatology (Baltimore, Md.) | 2014 | Yes |
Showing 5 of 29 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.